Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 546

Results For "ED"

9539 News Found

Zydus receives WHO prequalification for Miltefosine formulation and API
Drug Approval | February 26, 2024

Zydus receives WHO prequalification for Miltefosine formulation and API

Leishmaniasis is caused by protozoan parasites which are transmitted by the bite of infected female phlebotomine sandflies


VeerHealth Care announces expansion to enhance healthcare solutions
Healthcare | February 26, 2024

VeerHealth Care announces expansion to enhance healthcare solutions

VeerHealth Care will be raising Rs. 8 crores through bank borrowings


Max Healthcare to acquire land parcel in Lucknow for new hospital
News | February 26, 2024

Max Healthcare to acquire land parcel in Lucknow for new hospital

The board gave in-principle approval for expansion of company's footprint in Lucknow


Piramal Pharma gets Form 483 with 2 observations from USFDA for Lexington, USA facility
Drug Approval | February 26, 2024

Piramal Pharma gets Form 483 with 2 observations from USFDA for Lexington, USA facility

The observations do not pose any risk to site's compliance standards or its business continuity


India implementing largest digital programme for TB surveillance
News | February 24, 2024

India implementing largest digital programme for TB surveillance

Experts discussed the latest innovations, challenges, & collaborative solutions in the fight against TB at NHWIC-2024 held at AIIMS, Delhi


Orchid Pharma's 'Exblifep' receives USFDA approval
Drug Approval | February 24, 2024

Orchid Pharma's 'Exblifep' receives USFDA approval

Orchid is the first company from India, ever to have invented a product which has received a New Drug Approval (NDA) from USFDA


Moderna posts Q4 2023 revenue at US$ 2.8 billion
News | February 23, 2024

Moderna posts Q4 2023 revenue at US$ 2.8 billion

Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance


AstraZeneca completes acquisition of Gracell
News | February 23, 2024

AstraZeneca completes acquisition of Gracell

The acquisition enriches AstraZeneca’s growing pipeline of cell therapies with GC012F


Aptar Digital Health acquires Healint to broaden neurology portfolio
News | February 23, 2024

Aptar Digital Health acquires Healint to broaden neurology portfolio

The acquisition of Healint aligns with Aptar Digital Health’s strategy to broaden its portfolio in neurology and strengthen its global footprint for digital health deployment